Synthesis, characterization and antidiabetic effects of vanadyl(II) adenosine monophosphate amino acid mixed-ligand complexes

This research paper is aimed at designing a novel insulin alternative for the treatment of diabetes. Six novel vanadyl(II) compounds, [(AMP )(VO )(AA )]·NH , were synthesized from an equimolar ratio of adenosine monophosphate, VOSO and amino acids (AA ). The magnetic moments and electronic spectra r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Future medicinal chemistry 2019-02, Vol.11 (3), p.193-210
Hauptverfasser: Naglah, Ahmed M, Al-Omar, Mohamed A, Kalmouch, Atef, Alsuhaibani, Amnah MA, El-Didamony, Akram M, Hassan, Nader, Taleb, Sameh Abo, Refat, Moamen S, Almehizia, Abdulrahman A, Bhat, Mashooq A, Al-Shakliah, Nasser S, Al-Humaidi, Jehan Y, Al-Wasidi, Asma S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This research paper is aimed at designing a novel insulin alternative for the treatment of diabetes. Six novel vanadyl(II) compounds, [(AMP )(VO )(AA )]·NH , were synthesized from an equimolar ratio of adenosine monophosphate, VOSO and amino acids (AA ). The magnetic moments and electronic spectra revealed the square pyramidal geometrical structure of the complexes. In an study, the insulin levels, blood glucose levels, lipid profiles and histology of the pancreas and liver of the animals treated with the complexes were similar to those of healthy control animals, unlike the untreated and vanadyl sulfate(II)-treated diabetic ones. The data gathered in the current research illustrated that vanadyl(II)-AMP-amino acid (AA) mixed-ligand complexes can function as antidiabetic agents.
ISSN:1756-8919
1756-8927
DOI:10.4155/fmc-2018-0471